 CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 01, 2022 GLOBE NEWSWIRE -- Centogene N.V. Nasdaq: CNTG, the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule for December 2022. The Companys Pharma and CRO business development team and Diagnostics sales team will be attending events in the U.S. and Japan. CENTOGENE invites attendees to schedule one-on-one meetings. 